Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

246 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
10-day decitabine versus 3 + 7 chemotherapy followed by allografting in older patients with acute myeloid leukaemia: an open-label, randomised, controlled, phase 3 trial.
Lübbert M, Wijermans PW, Kicinski M, Chantepie S, Van der Velden WJFM, Noppeney R, Griškevičius L, Neubauer A, Crysandt M, Vrhovac R, Luppi M, Fuhrmann S, Audisio E, Candoni A, Legrand O, Foà R, Gaidano G, van Lammeren-Venema D, Posthuma EFM, Hoogendoorn M, Giraut A, Stevens-Kroef M, Jansen JH, de Graaf AO, Efficace F, Ammatuna E, Vilque JP, Wäsch R, Becker H, Blijlevens N, Dührsen U, Baron F, Suciu S, Amadori S, Venditti A, Huls G; EORTC Leukemia Group, GIMEMA, and German MDS Study Group. Lübbert M, et al. Among authors: hoogendoorn m. Lancet Haematol. 2023 Nov;10(11):e879-e889. doi: 10.1016/S2352-3026(23)00273-9. Lancet Haematol. 2023. PMID: 37914482 Free article. Clinical Trial.
First-Line Venetoclax Combinations in Chronic Lymphocytic Leukemia.
Eichhorst B, Niemann CU, Kater AP, Fürstenau M, von Tresckow J, Zhang C, Robrecht S, Gregor M, Juliusson G, Thornton P, Staber PB, Tadmor T, Lindström V, da Cunha-Bang C, Schneider C, Poulsen CB, Illmer T, Schöttker B, Nösslinger T, Janssens A, Christiansen I, Baumann M, Frederiksen H, van der Klift M, Jäger U, Leys MBL, Hoogendoorn M, Lotfi K, Hebart H, Gaska T, Koene H, Enggaard L, Goede J, Regelink JC, Widmer A, Simon F, De Silva N, Fink AM, Bahlo J, Fischer K, Wendtner CM, Kreuzer KA, Ritgen M, Brüggemann M, Tausch E, Levin MD, van Oers M, Geisler C, Stilgenbauer S, Hallek M; GCLLSG, the HOVON and Nordic CLL Study Groups, the SAKK, the Israeli CLL Association, and Cancer Trials Ireland. Eichhorst B, et al. Among authors: hoogendoorn m. N Engl J Med. 2023 May 11;388(19):1739-1754. doi: 10.1056/NEJMoa2213093. N Engl J Med. 2023. PMID: 37163621 Clinical Trial.
Fixed-duration venetoclax plus obinutuzumab improves quality of life and geriatric impairments in FCR-unfit patients with CLL.
van der Straten L, Stege CAM, Kersting S, Nasserinejad K, Dubois J, Dobber JA, Mellink CHM, van der Kevie-Kersemaekers AF, Evers LM, de Boer F, Koene HR, Schreurs J, van der Klift M, Velders GA, van der Spek E, van der Straaten HM, Hoogendoorn M, van Gelder M, Posthuma EFM, Visser HPJ, Houtenbos I, Idink CAM, Issa DE, Dompeling EC, van Zaanen HCT, Veelken JH, Levenga H, Tick LW, Terpstra WE, Tonino SH, Westerweel PE, Langerak AW, Kater AP, Levin MD. van der Straten L, et al. Among authors: hoogendoorn m. Blood. 2023 Sep 28;142(13):1131-1142. doi: 10.1182/blood.2023020195. Blood. 2023. PMID: 37363833 Free article.
The GLOW trial in chronic lymphocytic leukaemia.
van Gelder M, Hoogendoorn M, Te Raa D. van Gelder M, et al. Among authors: hoogendoorn m. Lancet Oncol. 2024 Feb;25(2):e55. doi: 10.1016/S1470-2045(23)00677-0. Lancet Oncol. 2024. PMID: 38301697 No abstract available.
The Evolution of Treatment Policies and Outcomes for Patients Aged 60 and Older with Acute Myeloid Leukemia: A Population-Based Analysis over Two Decades.
Diekmann B, Veeger N, Rozema J, Kibbelaar R, Franken B, Güler Y, Adema B, van Roon E, Hoogendoorn M; HemoBase Population Registry Consortium. Diekmann B, et al. Among authors: hoogendoorn m. Cancers (Basel). 2024 Nov 21;16(23):3907. doi: 10.3390/cancers16233907. Cancers (Basel). 2024. PMID: 39682095 Free PMC article.
Associations of Clinical Characteristics With Sudden Cardiac Arrest in People With Type 2 Diabetes With and Without Cardiovascular Disease: A Longitudinal Case-Control Study Using Routine Primary Care Data.
Harms PP, van Dongen LH, Bennis F, Swart KMA, Hoogendoorn M, Beulens JWJ, Tan HL, Elders PPJM, Blom MT; RESCUED Investigators. Harms PP, et al. Among authors: hoogendoorn m. Diabetes Care. 2025 Jan 1;48(1):125-135. doi: 10.2337/dc24-0715. Diabetes Care. 2025. PMID: 39556475
Midostaurin added to 10-day decitabine, for patients unfit for intensive chemotherapy with AML and higher risk MDS, irrespective of FLT3 mutational status, does not improve outcome.
Huls G, Chitu DA, Tick L, Boersma R, Breems D, Herbers A, Klein SK, de Jonge S, Westerweel PE, Cruijsen M, Hoogendoorn M, Cuijpers M, Deeren D, Bailly B, Visser O, van Rhenen A, Posthuma EFM, Valk PJM, Cloos J, Ammatuna E, Refos JM, Fakkert R, Löwenberg B, Ossenkoppele GJ. Huls G, et al. Among authors: hoogendoorn m. Ann Hematol. 2024 Oct 5. doi: 10.1007/s00277-024-06033-y. Online ahead of print. Ann Hematol. 2024. PMID: 39367118
Health care utilization up to 11 years after diagnosis among patients with a hematologic malignancy and its association with socioeconomic position.
Ekels A, van de Poll-Franse LV, Issa DE, Oosterveld M, van der Griend R, Hoogendoorn M, Koster A, Nijziel MR, Arts LPJ, Posthuma EFM, Oerlemans S. Ekels A, et al. Among authors: hoogendoorn m. J Cancer Surviv. 2024 Sep 17. doi: 10.1007/s11764-024-01676-2. Online ahead of print. J Cancer Surviv. 2024. PMID: 39287915
Impact of comorbidity on health-related quality of life in newly diagnosed patients with lymphoma or multiple myeloma: results from the PROFILES-registry.
Ekels A, van de Poll-Franse LV, Issa DE, Hoogendoorn M, Nijziel MR, Koster A, de Jong CN, Achouiti A, Thielen N, Tick LW, Te Boome LCJ, Bohmer LH, Tiren-Verbeet NL, Veldhuis GJ, de Boer F, van der Klift M, Posthuma EFM, Oerlemans S. Ekels A, et al. Among authors: hoogendoorn m. Ann Hematol. 2024 Sep 16. doi: 10.1007/s00277-024-06006-1. Online ahead of print. Ann Hematol. 2024. PMID: 39279019
Development of machine learning models predicting mortality using routinely collected observational health data from 0-59 months old children admitted to an intensive care unit in Bangladesh: critical role of biochemistry and haematology data.
Das S, Erdman L, Brals D, Boczek B, Hasan SMT, Massara P, Alam MA, Fahim SM, Mahfuz M, Hoogendoorn M, Zuiderent-Jerak T, Bandsma RHJ, Ahmed T, Voskuijl W. Das S, et al. Among authors: hoogendoorn m. BMJ Paediatr Open. 2024 Jul 22;8(1):e002365. doi: 10.1136/bmjpo-2023-002365. BMJ Paediatr Open. 2024. PMID: 39038911 Free PMC article.
246 results